Question 1

What is Benoit Tessoulin?

Accepted Answer

Benoit Tessoulin is a Person.

Question 2

How often does Benoit Tessoulin appear in global news?

Accepted Answer

Tracked across 1 news events drawn from 6 articles.

Question 3

When was Benoit Tessoulin first tracked by Ergen?

Accepted Answer

First tracked on Jun 11, 2026.

Question 4

When was Benoit Tessoulin last mentioned in news?

Accepted Answer

Last active on Jun 11, 2026.

Question 5

What is Benoit Tessoulin's current news sentiment?

Accepted Answer

Aggregate sentiment score: 0 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Benoit Tessoulin in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 1 events.

Question 7

What is the most recent event involving Benoit Tessoulin?

Accepted Answer

Genmab EPCORE FL-1 Trial Data (Jun 11, 2026, 6 articles).

Question 8

How did the "Genmab EPCORE FL-1 Trial Data" event impact Benoit Tessoulin?

Accepted Answer

Benoit Tessoulin, M.D., Ph.D., from Nantes University Hospital School of Medicine & University Hospital, provided expert commentary on the EPCORE FL-1 trial results, reinforcing the significance of epcoritamab in treating follicular lymphoma.

Question 9

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.